Cline Scientific, a life science company, agreed to acquire Liv Diagnostics, a medical devices provider. Financial terms were not disclosed. “After three years of being apart of a project that has resulted in the development of Liv Diagnostics, we are very excited to help play an even bigger key role in improving cancer care. Cline will now take over Liv Diagnostics, with the goal to take the company and the project to a point where we can speed up the development of the existing product and reduce fatalities among breast cancer patients.” Patrik Sundh, Cline Scientific CEO, President and co-founder.